FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3198682796> ?p ?o ?g. }

• W3198682796 endingPage "2716" @default.
• W3198682796 startingPage "2707" @default.
• W3198682796 abstract "Recently, there has been increased concern about a risk of secondary malignancies (SM) occurring in myelofibrosis (MF) patients receiving ruxolitinib (RUX). In polycythemia vera (PV), on the other hand, only limited data on the risk of SM under RUX treatment are available. To investigate the association between RUX therapy in PV and SM, we conducted a retrospective, single-center study that included 289 PV patients. RUX was administered to 32.9% (95/289) of patients for a median treatment duration of 48.0 months (range 1.0-101.6). Within a median follow-up of 97 months (1.0-395.0) after PV diagnosis, 24 SM occurred. Comparing the number of PV patients with RUX-associated SM (n = 10, 41.7%) with the 14 (58.3%) patients who developed SM without RUX, no significant difference (p = 0.34, chi square test) was found. No increased incidences of melanoma, lymphoma, or solid non-skin malignancies were observed with RUX (p = 0.31, p = 0.60, and p = 0.63, respectively, chi square test). However, significantly more NMSC occurred in association with RUX treatment (p = 0.03, chi-squared test). The SM-free survival was not significantly different by log rank test for all 289 patients (p = 0.65), for the patients (n = 208; 72%) receiving cytoreductive therapy (p = 0.48) or for different therapy sequences (p = 0.074). In multivariate analysis, advanced age at PV diagnosis (HR 1.062 [95% CI 1.028, 1.098]) but not administration of RUX (HR 1.068 [95% CI 0.468, 2.463]) was associated with an increased risk for SM (p = 0.005). According to this retrospective analysis, no increased risk of SM due to RUX treatment could be substantiated for PV." @default.
• W3198682796 created "2021-09-13" @default.
• W3198682796 creator A5006360930 @default.
• W3198682796 creator A5006909690 @default.
• W3198682796 creator A5008598512 @default.
• W3198682796 creator A5009616284 @default.
• W3198682796 creator A5032499177 @default.
• W3198682796 creator A5048314411 @default.
• W3198682796 creator A5049904099 @default.
• W3198682796 creator A5057840359 @default.
• W3198682796 creator A5063476572 @default.
• W3198682796 creator A5066999935 @default.
• W3198682796 creator A5083779854 @default.
• W3198682796 date "2021-08-31" @default.
• W3198682796 modified "2023-09-26" @default.
• W3198682796 title "Ruxolitinib-treated polycythemia vera patients and their risk of secondary malignancies" @default.
• W3198682796 cites W1919600052 @default.
• W3198682796 cites W2006787224 @default.
• W3198682796 cites W2009766779 @default.
• W3198682796 cites W2072881492 @default.
• W3198682796 cites W2089993696 @default.
• W3198682796 cites W2107398329 @default.
• W3198682796 cites W2112316414 @default.
• W3198682796 cites W2122395736 @default.
• W3198682796 cites W2158669800 @default.
• W3198682796 cites W2159533809 @default.
• W3198682796 cites W2405712018 @default.
• W3198682796 cites W2559562829 @default.
• W3198682796 cites W2783276969 @default.
• W3198682796 cites W2793344857 @default.
• W3198682796 cites W2808491541 @default.
• W3198682796 cites W2917089748 @default.
• W3198682796 cites W2935908830 @default.
• W3198682796 cites W2946901694 @default.
• W3198682796 cites W2948598785 @default.
• W3198682796 cites W2982450038 @default.
• W3198682796 cites W2994302264 @default.
• W3198682796 cites W3001373379 @default.
• W3198682796 cites W3038257434 @default.
• W3198682796 cites W3042034312 @default.
• W3198682796 cites W3095758083 @default.
• W3198682796 doi "https://doi.org/10.1007/s00277-021-04647-0" @default.
• W3198682796 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8510903" @default.
• W3198682796 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34462786" @default.
• W3198682796 hasPublicationYear "2021" @default.
• W3198682796 type Work @default.
• W3198682796 sameAs 3198682796 @default.
• W3198682796 citedByCount "10" @default.
• W3198682796 countsByYear W31986827962021 @default.
• W3198682796 countsByYear W31986827962022 @default.
• W3198682796 countsByYear W31986827962023 @default.
• W3198682796 crossrefType "journal-article" @default.
• W3198682796 hasAuthorship W3198682796A5006360930 @default.
• W3198682796 hasAuthorship W3198682796A5006909690 @default.
• W3198682796 hasAuthorship W3198682796A5008598512 @default.
• W3198682796 hasAuthorship W3198682796A5009616284 @default.
• W3198682796 hasAuthorship W3198682796A5032499177 @default.
• W3198682796 hasAuthorship W3198682796A5048314411 @default.
• W3198682796 hasAuthorship W3198682796A5049904099 @default.
• W3198682796 hasAuthorship W3198682796A5057840359 @default.
• W3198682796 hasAuthorship W3198682796A5063476572 @default.
• W3198682796 hasAuthorship W3198682796A5066999935 @default.
• W3198682796 hasAuthorship W3198682796A5083779854 @default.
• W3198682796 hasBestOaLocation W31986827961 @default.
• W3198682796 hasConcept C126322002 @default.
• W3198682796 hasConcept C2776112149 @default.
• W3198682796 hasConcept C2778837598 @default.
• W3198682796 hasConcept C2780007613 @default.
• W3198682796 hasConcept C2780076729 @default.
• W3198682796 hasConcept C71924100 @default.
• W3198682796 hasConcept C90924648 @default.
• W3198682796 hasConceptScore W3198682796C126322002 @default.
• W3198682796 hasConceptScore W3198682796C2776112149 @default.
• W3198682796 hasConceptScore W3198682796C2778837598 @default.
• W3198682796 hasConceptScore W3198682796C2780007613 @default.
• W3198682796 hasConceptScore W3198682796C2780076729 @default.
• W3198682796 hasConceptScore W3198682796C71924100 @default.
• W3198682796 hasConceptScore W3198682796C90924648 @default.
• W3198682796 hasIssue "11" @default.
• W3198682796 hasLocation W31986827961 @default.
• W3198682796 hasLocation W31986827962 @default.
• W3198682796 hasLocation W31986827963 @default.
• W3198682796 hasLocation W31986827964 @default.
• W3198682796 hasLocation W31986827965 @default.
• W3198682796 hasOpenAccess W3198682796 @default.
• W3198682796 hasPrimaryLocation W31986827961 @default.
• W3198682796 hasRelatedWork W2012828222 @default.
• W3198682796 hasRelatedWork W2101002658 @default.
• W3198682796 hasRelatedWork W2137226206 @default.
• W3198682796 hasRelatedWork W2400428203 @default.
• W3198682796 hasRelatedWork W2726232197 @default.
• W3198682796 hasRelatedWork W2743252677 @default.
• W3198682796 hasRelatedWork W2957228011 @default.
• W3198682796 hasRelatedWork W3081519486 @default.
• W3198682796 hasRelatedWork W4243083287 @default.
• W3198682796 hasRelatedWork W4249090175 @default.
• W3198682796 hasVolume "100" @default.
• W3198682796 isParatext "false" @default.

• next